Literature DB >> 3256572

Field evaluation of the Copal UA-231 automatic sphygmomanometer.

S Rogers1, G D Smith, W Doyle.   

Abstract

Automated sphygmomanometers should be evaluated in field studies before being recommended for epidemiological use. In this study an automated sphygmomanometer, the Copal UA-231, was evaluated on the basis of duplicate blood pressure measurements, one with this machine and one with a Hawksley random zero machine, taken on 1536 participants in a health survey. The Copal-random zero differences had a mean of 2.3 mm Hg for systolic blood pressure and 1.9 mm Hg for diastolic pressure, the Copal reading higher than the random zero. The standard deviations of these differences were similar to the standard deviations of the differences between two random zero measurements taken on subjects in a separate survey. However, Copal-random zero differences varied systemically with blood pressure levels. In this study a 10 mm Hg increase in systolic blood pressure was associated with a 1.22 mm Hg increase in the Copal-random zero difference and a 10 mm Hg increase in diastolic blood pressure was associated with a 1.15 mm Hg increase in the Copal-random zero difference. The Copal UA-231 is recommended for use in field surveys, but it should be recognised that a small systematic increase in Copal-random zero difference with increasing blood pressure may complicate interpretation of epidemiological associations.

Entities:  

Mesh:

Year:  1988        PMID: 3256572      PMCID: PMC1052759          DOI: 10.1136/jech.42.4.321

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  8 in total

1.  STANDARDISATION OF OBSERVERS IN BLOOD-PRESSURE MEASUREMENT.

Authors:  G ROSE
Journal:  Lancet       Date:  1965-03-27       Impact factor: 79.321

2.  Standards for blood pressure measuring devices.

Authors:  E O'Brien; J C Petrie; W A Littler; M de Swiet
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-16

3.  Evaluation of performance of selected devices for measuring blood pressure.

Authors:  D R Labarthe; C M Hawkins; R D Remington
Journal:  Am J Cardiol       Date:  1973-09-20       Impact factor: 2.778

4.  Experience with the random-zero sphygmomanometer.

Authors:  J G Evans; I A Prior
Journal:  Br J Prev Soc Med       Date:  1970-02

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Automatic measurement of blood pressure: evaluation of the Copal UA-231 automatic sphygmomanometer.

Authors:  J E Gallacher; J W Yarnell; S Rogers; P Sweetnam
Journal:  J Epidemiol Community Health       Date:  1985-09       Impact factor: 3.710

7.  The random-zero versus the standard mercury sphygmomanometer: a systematic blood pressure difference.

Authors:  R de Gaudemaris; A R Folsom; R J Prineas; R V Luepker
Journal:  Am J Epidemiol       Date:  1985-02       Impact factor: 4.897

8.  Changing relation between home and clinic blood-pressure measurements: do home measurements predict clinic hypertension?

Authors:  P L Padfield; B A Lindsay; J A McLaren; A Pirie; M Rademaker
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

  8 in total
  3 in total

1.  Measurement error in the Hawksley random zero sphygmomanometer: what damage has been done and what can we learn?

Authors:  R M Conroy; E O'Brien; K O'Malley; N Atkins
Journal:  BMJ       Date:  1993-05-15

2.  Pressor reactions to psychological stress and prediction of future blood pressure: data from the Whitehall II Study.

Authors:  D Carroll; G D Smith; D Sheffield; M J Shipley; M G Marmot
Journal:  BMJ       Date:  1995-03-25

3.  Community-based blood pressure measurement by non-health workers using electronic devices: a validation study.

Authors:  Daniel D Reidpath; Mei Lee Ling; Shajahan Yasin; Kanason Rajagobal; Pascale Allotey
Journal:  Glob Health Action       Date:  2012-06-27       Impact factor: 2.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.